如何管理多血管动脉粥样硬化疾病患者：国际血管联盟立场文件

2021-11-01 国际血管联盟 Int Angiol . 2021 Feb;40(1):29-41

动脉粥样硬化是一种影响多个动脉区域的全身性疾病。一个血管床有临床动脉粥样硬化疾病的患者，很可能在其他血管床有无症状或有症状的动脉粥样硬化病变。具体而言，外周动脉疾病 (PAD) 通常与冠状动脉和颈动脉

中文标题：

英文标题：

How to manage patients with polyvascular atherosclerotic disease. Position paper of the International Union of Angiology

发布机构：

国际血管联盟

发布日期：

2021-11-01

简要介绍：

动脉粥样硬化是一种影响多个动脉区域的全身性疾病。一个血管床有临床动脉粥样硬化疾病的患者，很可能在其他血管床有无症状或有症状的动脉粥样硬化病变。具体而言，外周动脉疾病 (PAD) 通常与冠状动脉和颈动脉疾病共存。随着一个血管床动脉粥样硬化疾病的进展，其他地区临床表现的风险增加，心血管不良事件的发生率随着受累血管床数量的增加而显着增加。经典风险因素与不同地区多血管动脉粥样硬化疾病 (PVD) 的发展有关；然而，程度不同。风险修正代表 PVD 患者的基本治疗。所有可改变的风险因素都应通过改变生活方式和药物来积极控制。应特别注意 PAD 患者，尽管基于指南的方法已证明其益处，但仍经常治疗不足。目前没有证据表明无症状动脉粥样硬化和 PVD 的识别可以改善已经参与预防计划的患者的临床结果。血运重建应仅在有症状的血管床中进行，根据多学科血管团队的共识决定使用最不激进的方法。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=3fe6c1c002256e23, title=如何管理多血管动脉粥样硬化疾病患者：国际血管联盟立场文件 , enTitle=How to manage patients with polyvascular atherosclerotic disease. Position paper of the International Union of Angiology, guiderFrom=Int Angiol . 2021 Feb;40(1):29-41, authorId=0, author=, summary=动脉粥样硬化是一种影响多个动脉区域的全身性疾病。一个血管床有临床动脉粥样硬化疾病的患者，很可能在其他血管床有无症状或有症状的动脉粥样硬化病变。具体而言，外周动脉疾病 (PAD) 通常与冠状动脉和颈动脉, cover=, journalId=0, articlesId=null, associationId=1013, associationName=国际血管联盟, associationIntro=国际血管联盟（International Union of Angiology, IUA）,创建于1950年。这是一个以血管外科医师为主导的血管相关学科医师参与的大型国际学术组织。目前拥有73个国家的数千名会员，每2年在世界各地召开国际学术活动，积极开展相关的学术交流。, copyright=0, guiderPublishedTime=Mon Nov 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=动脉粥样硬化是一种影响多个动脉区域的全身性疾病。一个血管床有临床动脉粥样硬化疾病的患者，很可能在其他血管床有无症状或有症状的动脉粥样硬化病变。具体而言，外周动脉疾病 (PAD) 通常与冠状动脉和颈动脉疾病共存。随着一个血管床动脉粥样硬化疾病的进展，其他地区临床表现的风险增加，心血管不良事件的发生率随着受累血管床数量的增加而显着增加。经典风险因素与不同地区多血管动脉粥样硬化疾病 (PVD) 的发展有关；然而，程度不同。风险修正代表 PVD 患者的基本治疗。所有可改变的风险因素都应通过改变生活方式和药物来积极控制。应特别注意 PAD 患者，尽管基于指南的方法已证明其益处，但仍经常治疗不足。目前没有证据表明无症状动脉粥样硬化和 PVD 的识别可以改善已经参与预防计划的患者的临床结果。血运重建应仅在有症状的血管床中进行，根据多学科血管团队的共识决定使用最不激进的方法。, tagList=[TagDto(tagId=828, tagName=动脉粥样硬化)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1887, appHits=66, showAppHits=0, pcHits=315, showPcHits=1821, likes=2, shares=2, comments=6, approvalStatus=1, publishedTime=Tue Nov 16 23:57:01 CST 2021, publishedTimeString=2021-11-01, pcVisible=1, appVisible=1, editorId=4754896, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=小小医者, createdTime=Sat Nov 06 21:15:05 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 20:10:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=1.pdf)])

1.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1232140, encodeId=40ef1232140be, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Tue Jul 12 23:25:24 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192970, encodeId=998211929e087, content=非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83566493446, createdName=ms2000000789088268, createdTime=Sun Feb 13 14:52:30 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074191, encodeId=e8ec10e41918b, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:08:20 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069085, encodeId=353a106908572, content=一个人都没有吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7bc5688177, createdName=ms8000001716205745, createdTime=Wed Nov 10 21:21:40 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
2022-07-12 ms7000001124466419

非常实用

41 0
[GetPortalCommentsPageByObjectIdResponse(id=1232140, encodeId=40ef1232140be, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Tue Jul 12 23:25:24 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192970, encodeId=998211929e087, content=非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83566493446, createdName=ms2000000789088268, createdTime=Sun Feb 13 14:52:30 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074191, encodeId=e8ec10e41918b, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:08:20 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069085, encodeId=353a106908572, content=一个人都没有吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7bc5688177, createdName=ms8000001716205745, createdTime=Wed Nov 10 21:21:40 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
2022-02-13 ms2000000789088268

非常不错

53 0
[GetPortalCommentsPageByObjectIdResponse(id=1232140, encodeId=40ef1232140be, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Tue Jul 12 23:25:24 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192970, encodeId=998211929e087, content=非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83566493446, createdName=ms2000000789088268, createdTime=Sun Feb 13 14:52:30 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074191, encodeId=e8ec10e41918b, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:08:20 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069085, encodeId=353a106908572, content=一个人都没有吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7bc5688177, createdName=ms8000001716205745, createdTime=Wed Nov 10 21:21:40 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
2021-11-26 H8888888

不错学习了

61 0
[GetPortalCommentsPageByObjectIdResponse(id=1232140, encodeId=40ef1232140be, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Tue Jul 12 23:25:24 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192970, encodeId=998211929e087, content=非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83566493446, createdName=ms2000000789088268, createdTime=Sun Feb 13 14:52:30 CST 2022, time=2022-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074191, encodeId=e8ec10e41918b, content=不错学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:08:20 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069085, encodeId=353a106908572, content=一个人都没有吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7bc5688177, createdName=ms8000001716205745, createdTime=Wed Nov 10 21:21:40 CST 2021, time=2021-11-10, status=1, ipAttribution=)]
2021-11-10 ms8000001716205745

一个人都没有吗

62 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

如何管理多血管动脉粥样硬化疾病患者：国际血管联盟立场文件

相关指南

科室

工具

服务